-
公开(公告)号：US20220259320A1
公开(公告)日：2022-08-18
申请号：US17682922
申请日：2022-02-28
发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
-
公开(公告)号：US11999789B2
公开(公告)日：2024-06-04
申请号：US17682922
申请日：2022-02-28
发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
IPC分类号： C07K16/24 , A61P1/04 , C07K16/28 , A61K39/395 , C07K14/52 , C07K14/525
CPC分类号： C07K16/2875 , A61P1/04 , C07K16/241 , C07K2317/21 , C07K2317/24 , C07K2317/40 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/76
摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
-
公开(公告)号：US20230192835A1
公开(公告)日：2023-06-22
申请号：US17931049
申请日：2022-09-09
发明人： Jeffry D. Watkins , Cindy T. Dickerson , J. Monty Watkins , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
CPC分类号： C07K16/24 , A61P1/04 , C07K16/241 , C07K16/28 , A61P1/00 , A61K9/0019 , C07K16/2875 , C12N15/09 , C12N15/63 , C12N5/10 , A61K39/3955
摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
-
公开(公告)号：US20240327532A1
公开(公告)日：2024-10-03
申请号：US18645261
申请日：2024-04-24
发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
CPC分类号： C07K16/2875 , A61P1/04 , C07K16/241 , C07K2317/21 , C07K2317/24 , C07K2317/40 , C07K2317/51 , C07K2317/515 , C07K2317/56 , C07K2317/76
摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
-
公开(公告)号：US11440954B2
公开(公告)日：2022-09-13
申请号：US16863971
申请日：2020-04-30
发明人： Jeffry D. Watkins , Cindy T. Dickerson , J. Monty Watkins , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
IPC分类号： C07K16/24 , C07K16/28 , C12N5/10 , C12N15/09 , C12N15/63 , A61P1/04 , A61P1/00 , A61K9/00 , C07K14/525 , C07K14/715 , A61K39/395 , A61K39/00
摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
-
公开(公告)号：US11292848B2
公开(公告)日：2022-04-05
申请号：US17110004
申请日：2020-12-02
发明人： Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
IPC分类号： C07K16/24 , C07K16/28 , A61P1/04 , C07K14/52 , C07K14/525 , A61K39/395
摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
-
公开(公告)号：US20190247498A1
公开(公告)日：2019-08-15
申请号：US16384521
申请日：2019-04-15
CPC分类号： A61K39/39533 , A61K39/3955 , A61K48/005 , A61K2039/505 , A61P1/02 , A61P29/00 , A61P37/00 , C07K16/241 , C07K16/2809 , C07K16/2875 , C07K2317/24 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92
摘要： Described herein are methods and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), Crohn's Disease (CD), ulcerative colitis (UC) and medically refractive-ulcerative colitis (MR-UC). In particular, disclosed are anti-TL1A antibodies useful for the treatment of IBD.
-
公开(公告)号：US20230381308A1
公开(公告)日：2023-11-30
申请号：US18191712
申请日：2023-03-28
CPC分类号： A61K39/39533 , C07K16/241 , C07K16/2875 , A61P37/00 , A61P1/02 , A61P29/00 , A61K48/005 , C07K16/2809 , C07K2317/56 , A61K2039/505
摘要： Described herein are methods and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), Crohn's Disease (CD), ulcerative colitis (UC) and medically refractive-ulcerative colitis (MR-UC). In particular, disclosed are anti-TL1A antibodies useful for the treatment of IBD.
-
公开(公告)号：US10322174B2
公开(公告)日：2019-06-18
申请号：US15792266
申请日：2017-10-24
IPC分类号： C07K16/24 , A61K39/395 , A61P37/00 , A61P1/02 , A61P29/00 , A61K48/00 , C07K16/28 , C07K14/525 , A61K39/00
摘要： Described herein are methods and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), Crohn's Disease (CD), ulcerative colitis (UC) and medically refractive-ulcerative colitis (MR-UC). In particular, disclosed are anti-TL1A antibodies useful for the treatment of IBD.
-
公开(公告)号：US20180110855A1
公开(公告)日：2018-04-26
申请号：US15792266
申请日：2017-10-24
CPC分类号： A61K39/39533 , A61K48/005 , A61P1/02 , A61P29/00 , A61P37/00 , C07K16/2809 , C07K2317/24 , C07K2317/565 , C07K2317/76 , C07K2317/90
摘要： Described herein are methods and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), Crohn's Disease (CD), ulcerative colitis (UC) and medically refractive-ulcerative colitis (MR-UC). In particular, disclosed are anti-TL1A antibodies useful for the treatment of IBD.
-
-
-
-
-
-
-
-
-
搜索结果
11 条记录 (耗时 0.019 秒)
